Citius Pharmaceuticals, Inc. (CTXR)

Citius Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	7.72	4.25	3.25	26.48	41.71	70.07
Cash & Short-Term Investments	7.72	4.25	3.25	26.48	41.71	70.07
Cash Growth	601.89%	30.76%	-87.72%	-36.51%	-40.47%	405.59%
Receivables	4.05	-	-	-	-	-
Inventory	22.64	22.29	8.27	-	-	-
Prepaid Expenses	3.54	1.4	2.7	7.89	2.85	2.74
Total Current Assets	37.95	27.93	14.22	34.37	44.56	72.81
Property, Plant & Equipment	0.84	0.82	0.25	0.46	0.65	0.83
Goodwill	9.35	9.35	9.35	9.35	9.35	9.35
Other Intangible Assets	92.23	92.8	92.8	59.4	59.4	59.4
Other Long-Term Assets	0.04	0.04	0.04	0.04	0.04	0.04
Total Assets	140.39	130.94	116.65	103.61	114	142.43
Accounts Payable	11.02	13.69	4.93	2.93	1.17	1.28
Accrued Expenses	7.79	7.48	2.25	2.63	3.17	2.53
Short-Term Debt	1	1	-	-	-	-
Current Portion of Leases	0.15	0.09	0.24	0.22	0.2	0.18
Other Current Liabilities	18.25	22.65	28.4	-	-	-
Total Current Liabilities	38.21	44.91	35.81	5.78	4.53	3.98
Long-Term Leases	0.68	0.72	0.02	0.26	0.48	0.68
Long-Term Deferred Tax Liabilities	8.04	7.77	6.71	6.14	5.56	4.99
Total Liabilities	46.92	53.41	42.55	12.18	10.57	9.65
Common Stock	0.02	0.02	0.01	0.01	0.15	0.15
Additional Paid-In Capital	326.96	306.34	271.44	253.06	232.37	228.08
Retained Earnings	-247.02	-238.8	-201.37	-162.23	-129.69	-96.05
Total Common Equity	79.96	67.55	70.08	90.83	102.83	132.18
Minority Interest	13.51	9.98	4.02	0.6	0.6	0.6
Shareholders' Equity	93.47	77.53	74.1	91.43	103.43	132.78
Total Liabilities & Equity	140.39	130.94	116.65	103.61	114	142.43
Total Debt	1.83	1.81	0.26	0.48	0.68	0.86
Net Cash (Debt)	5.89	2.44	2.99	26	41.03	69.22
Net Cash Growth	557.92%	-18.40%	-88.50%	-36.64%	-40.72%	453.40%
Net Cash Per Share	0.40	0.22	0.44	4.30	7.02	15.93
Filing Date Shares Outstanding	22.38	20.76	7.73	6.36	5.85	5.84
Total Common Shares Outstanding	22.38	18.07	7.25	6.35	5.85	5.84
Working Capital	-0.26	-16.98	-21.59	28.59	40.03	68.83
Book Value Per Share	3.57	3.74	9.67	14.29	17.58	22.64
Tangible Book Value	-21.62	-34.6	-32.07	22.08	34.08	63.44
Tangible Book Value Per Share	-0.97	-1.91	-4.43	3.48	5.83	10.86

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q